Modern climbers have the opposite problem. Go to any outdoor recreation store and prepare to be overwhelmed by shelves of cutting-edge climbing shoes and marketing gibberish. That’s how I felt ...

In this article, we are going to take a look at where Tenaya Therapeutics, Inc. (NASDAQ:TNYA) stands against other cheapest stocks insiders are buying in March. After solid gains Monday ...

SOUTH SAN FRANCISCO, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver ...

Tenaya Therapeutics (TNYA) announced that it intends to offer and sell units consisting of common stock and Series A warrants and Series B warrants, each to purchase shares of common stock. The ...

Chardan lowered the firm’s price target on Tenaya Therapeutics (TNYA) to $9 from $18 and keeps a Buy rating on the shares. The firm’s updated model incorporates equity dilution from the March ...

Tenaya Therapeutics, Inc. announced that it will present new data on its MYBPC3-associated hypertrophic cardiomyopathy (HCM) program at the American College of Cardiology's Annual Scientific ...

A REVOLUTIONARY mountaineer who invented the five-fingered climbing shoe has plunged to his death after falling from a peak in Italy. Married dad and mountain sports enthusiast Robert Fliri ...

SOUTH SAN FRANCISCO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver ...

In this article, we are going to take a look at where Tenaya Therapeutics, Inc. (NASDAQ:TNYA) stands against other stocks that are receiving the most insider investment in March. “The economy is ...

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver ...